Redeeflu (M2SR) Influenza Vaccine — Vax-Before-Travel

Redeeflu (M2SR) Influenza Vaccine

Fact checked by Holly Lutmer PharmD

Aug 2

6 min read

Flu Vaccine Candidate Demonstrated Multi-Seasonal, Seven-Year Drifted Influenza Strain Protection

Flugen Inc.’s Redeeflu M2SR is a supra-seasonal, live, single-replication, intranasal flu vaccine.

woman taking a nasal spary for the flu

Fact checked by Robert Carlson, MD

Jun 26

3 min read

Flu Shot ‘Primer’ Study Launches in St. Louis

M2SR vaccine candidate primer could better protect children and minimize viral transmission

people in line to volunteer

Fact checked by Kelley Lu, PharmD

Feb 12

4 min read

Nasal Spray Flu Vaccine Candidate Announced Positive Results

FluGen’s M2SR influenza vaccine candidate demonstrated protection against multi-season mismatched H3N2 strain in a human challenge clinical trial

mom and child wrinkling nose